1.指南来源（Guide Source）:

NCCN临床实践指南:T细胞淋巴瘤 V1.2027.发布已获NCCN肿瘤学临床实践指南(NCCN指南®)许可。©2026美国国家综合癌症网络公司.保留所有权利。未经NCCN明确的书面许可，不得出于任何目的以任何形式复制NCCN指南®和文中的插图。要查看NCCN指南的最新完整版本，请访问NCCN.org。NCCN指南是一项持续进行的工作，可能会随着新的重要数据的出现而不断完善。 

2.免责声明（Disclaimers）：

NCCN对其内容、使用或应用不做任何形式的担保，并否认以任何方式对其应用或使用承担任何责任。

在下载本篇指南前，请先您详细阅读并同意以下协议：

NCCN内容不得用于商业目的，以及NCCN作为NCCN内容的许可方，不作任何陈述或保证，并明确否认NCCN指南适用于任何特定患者的护理或治疗，任何医院、寻求使用《NCCN指南》治疗患者的临床医生或其他医疗服务提供者(“提供者”)应根据特定患者护理或治疗的具体临床情况做出独立的医疗判断，NCCN不建议、推荐或认可任何提供者(无论是否与被许可方相关)进行任何有偿或无偿的医疗治疗、咨询或服务，也不应因被许可方建议、推荐或认可任何此类提供者的作为或不作为而直接或间接承担责任。详见《NCCN最终用户许可协议》

3.专家名单（Staff）：

*Steven M. Horwitz, MD/Chair † Þ Memorial Sloan Kettering Cancer Center

*Stephen Ansell, MD, PhD/Vice-Chair ‡ Mayo Clinic Cancer Center

Weiyun Z. Ai, MD, PhD † ‡ UCSF Helen Diller Family Comprehensive Cancer Center

Jeffrey Barnes, MD, PhD † Massachusetts General Hospital Cancer Center

*Stefan K. Barta, MD, MRCP, MS † ‡ Abramson Cancer Center at the University of Pennsylvania

*Jonathan Brammer, MD ‡ The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

*Mark W. Clemens, MD ʘ The University of Texas MD Anderson Cancer Center

Ahmet Dogan, MD, PhD ≠ Memorial Sloan Kettering Cancer Center

Francine Foss, MD † ‡ ξ Yale Cancer Center/Smilow Cancer Hospital

*Paola Ghione, MD ‡ Roswell Park Comprehensive Cancer Center

*Aaron M. Goodman, MD ‡ ξ UC San Diego Moores Cancer Center

Joan Guitart, MD ≠ ϖ Robert H. Lurie Comprehensive Cancer Center of Northwestern University 

*Ahmad Halwani, MD ‡ Huntsman Cancer Institute at the University of Utah

*Bradley M. Haverkos, MD, MPH, MS † University of Colorado Cancer Center

Richard T. Hoppe, MD § Stanford Cancer Institute

Eric Jacobsen, MD † Dana-Farber/Brigham and Women's Cancer Center

*Deepa Jagadeesh, MD, MPH † ‡ Case Comprehensive Cancer Center/ University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

Allison Jones, MD ϖ St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

Avyakta Kallam, MD,MBBS Þ Fred & Pamela Buffett Cancer Center

Youn H. Kim, MD ϖ † Stanford Cancer Institute

Kiran Kumar, MD, MBA § UT Southwestern Simmons Comprehensive Cancer Center

*Neha Mehta-Shah, MD, MSCI † ‡ Siteman Cancer Center at Barnes- Jewish Hospital and Washington University School of Medicine

Elise A. Olsen, MD ϖ † Duke Cancer Institute

Saurabh A. Rajguru, MD † ‡ University of Wisconsin Carbone Cancer Center

Sima Rozati, MD, PhD ϖ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins *Jonathan Said, MD ≠ UCLA Jonsson Comprehensive Cancer Center

Aaron Shaver, MD, PhD ≠ Vanderbilt-Ingram Cancer Center

*Lauren Shea, MD ‡ O'Neal Comprehensive Cancer Center at UAB

*Michi M. Shinohara, MD ϖ ≠ Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance

*Lubomir Sokol, MD, PhD † ‡ Þ Moffitt Cancer Center

Carlos Torres-Cabala, MD ≠ The University of Texas MD Anderson Cancer Center

*Ryan Wilcox, MD, PhD † ‡ University of Michigan Rogel Cancer Center

*Peggy Wu, MD, MPH ϖ UC Davis Comprehensive Cancer Center

Jasmine Zain, MD † ‡ City of Hope National Medical Center

NCCN Mary Dwyer, MS Hema Sundar, PhD 

4.临床试验（Clinical Trials）：

NCCN认为任何癌症患者都可以在临床试验中得到最佳治疗，因此特别鼓励患者参与临床试验。 寻找NCCN成员组：https://www.nccn.org/home/member-institutions

5.NCCN对证据和共识分类（ NCCN Categories of Evidence and Consensus）：

推荐均为2A类，除非另有说明，请参见下表： 

6.NCCN首选分类（ NCCN Categories of Preference）：

所有建议均视为合理，请参见下表：